Form 4: Ingevity SVP Phillip Platt Receives RSU Grant
Statement of Changes in Beneficial Ownership
Ingevity Corporation SVP of Finance and CAO Phillip J. Platt was granted 1,262 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.
Summary
- Phillip J. Platt, SVP of Finance and CAO of Ingevity Corp, received a grant of 1,262 restricted stock units (RSUs).
- The RSUs were granted under the Ingevity Corporation 2025 Omnibus Incentive Plan.
- The grant vests in three equal annual installments beginning May 1, 2027, and concluding May 1, 2029.
- The reporting person's total beneficial ownership following the transaction is 31,633 shares of common stock.
- The total includes 422 shares acquired through the Employee Stock Purchase Plan (ESPP) for the period ending March 31, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected and does not signal a change in company strategy or financial health.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Continued participation in the company's Employee Stock Purchase Plan, indicating executive confidence.
Negatives
- None identified in this filing.
Risks
- Standard market risks associated with equity ownership and share price volatility.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on executive equity compensation.
Industry Context
StockSavvy.ai notes that routine equity grants to senior executives are standard corporate governance practices designed to incentivize long-term performance and retention within the specialty chemicals sector.
Comparison to Industry Standards
- The use of multi-year vesting schedules for RSUs is consistent with standard executive compensation practices at peer companies like Eastman Chemical or Westlake Corporation.
- Participation in an ESPP is a common benefit offered to employees and executives to encourage equity ownership.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation grant.
Next Steps
- Vesting of the first tranche of RSUs on May 1, 2027.
Key Dates
| Date | Description |
|---|---|
| 01/01/2026 | Start of ESPP purchase period |
| 12/31/2025 | Reference date for ESPP purchase price calculation |
| 03/31/2026 | End of ESPP purchase period |
| 05/01/2026 | Date of RSU grant transaction |
| 05/05/2026 | Filing date of Form 4 |
| 05/01/2027 | First vesting date for RSU grant |
Keywords
Ingevity, NGVT, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.